Oral Covid Vaccine May Be Game Changer

Click For Summary
Pfizer has initiated a Phase 1 study for a novel oral antiviral therapeutic agent targeting SARS-CoV-2, specifically a protease inhibitor. This development could significantly impact the treatment landscape for COVID-19, although it is important to clarify that this is not a vaccine. The discussion highlights a mix-up regarding the nature of the treatment, with one participant mistakenly referencing it as a vaccine. Another link shared discusses an Israeli company's progress on an oral COVID-19 vaccine, indicating that advancements in both treatment and vaccine development are ongoing. Overall, the conversation emphasizes the evolving nature of COVID-19 therapeutics.
Biology news on Phys.org
This is not a vaccine. As the title of the press release says, this is a "ORAL ANTIVIRAL THERAPEUTIC AGENT AGAINST SARS-COV-2," specifically a protease inhibitor drug.

(I find it ironic that @FactChecker liked the erroneous post without first checking the facts :smile:)
 
Last edited:
  • Like
Likes Vanadium 50, bhobba and TeethWhitener
Ygggdrasil said:
(I find it ironic that @FactChecker liked the erroneous post without first checking the facts :smile:)

Don't blame him - it was my mistake in not reading it carefully enough. The following, unless I made a similar goof, seems an actual vaccine:
https://www.jpost.com/health-science/israeli-company-says-oral-covid-19-vaccine-on-its-way-662712

Either way the 'treatment' landscape seems to be hotting up.

Thanks
Bill